Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Cagrilintide is a synthetic long-acting amylin analog currently under investigation for its role in appetite regulation, energy intake, and metabolic homeostasis. It mimics the activity of endogenous amylin—a peptide hormone co-secreted with insulin—and is studied for its effects on satiety signaling, slowed gastric emptying, and nutrient sensing. Research models have explored its use in combination with GLP-1 receptor agonists to evaluate dual-pathway metabolic modulation. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.
Cagrilintide is a synthetic long-acting amylin analog currently under investigation for its role in appetite regulation, energy intake, and metabolic homeostasis. It mimics the activity of endogenous amylin—a peptide hormone co-secreted with insulin—and is studied for its effects on satiety signaling, slowed gastric emptying, and nutrient sensing. Research models have explored its use in combination with GLP-1 receptor agonists to evaluate dual-pathway metabolic modulation. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.